Skip to main content
. 2022 Sep 23;13:997270. doi: 10.3389/fimmu.2022.997270

Table 1.

Diagnostic assessment of NAFLD/NASH.

Clinical examination
Physical examination, exclusion of alcohol consumption and other causes of chronic liver disease
Serum markers and biochemical indexes
Liver profile biomarkers
Biomarkers of inflammation and fibrosis
Imaging tests
Abdominal ultrasonography
Transient elastography (Fibroscan® )
Controlled attenuation parameter (CAP™, Fibroscan® )
Computed tomography (CT)
Magnetic resonance imaging (MRI)
Liver biopsy